Drug Type Small molecule drug |
Synonyms N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide |
Target |
Mechanism COX-2 inhibitors(Cyclooxygenase-2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC13H18N2O5S |
InChIKeyKTDZCOWXCWUPEO-UHFFFAOYSA-N |
CAS Registry123653-11-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Phase 1 | - | - | |
Inflammation | Phase 1 | JP | - | |
Neoplasms | Phase 1 | GB | - | - |
Renal Colic | Phase 1 | US | - | - |
Not Applicable | - | tlnukgmlyn(ypocythtdh) = mzhfmzywbm eitpkkpcmp (revdrjqbpg ) View more | - | 11 Nov 2014 | |||
High Phosphate (HP) (4mM) with EP2 receptor antagonist (AH6809 10 -7 mM) | tlnukgmlyn(ypocythtdh) = mszedkojyw eitpkkpcmp (revdrjqbpg ) View more | ||||||
Not Applicable | MMP-13 | - | (tseuulftwo) = jxhxlowffl ndcukrnlyr (ceqphcopdf ) | Positive | 18 Jun 2003 | ||
(tseuulftwo) = aqzxrjtfyb ndcukrnlyr (ceqphcopdf ) |